187 related articles for article (PubMed ID: 12351485)
21. Serum concentrations of nitric oxide, tumor necrosis factor (TNF)-alpha and TNF soluble receptors in women with overweight and obesity.
Olszanecka-Glinianowicz M; Zahorska-Markiewicz B; Janowska J; Zurakowski A
Metabolism; 2004 Oct; 53(10):1268-73. PubMed ID: 15375781
[TBL] [Abstract][Full Text] [Related]
22. [Serum concentrations of tumor necrosis factor TNFalpha and its soluble receptors in obese women with diabetes type 2 and without additional disease].
Olszanecka-Glinianowicz M; Waluszek-Kończakowska I; Zahorska-Markiewicz B; Janowska J
Endokrynol Pol; 2005; 56(2):174-8. PubMed ID: 16335686
[TBL] [Abstract][Full Text] [Related]
23. Plasma concentrations of soluble TNF-alpha receptors in obese subjects.
Hauner H; Bender M; Haastert B; Hube F
Int J Obes Relat Metab Disord; 1998 Dec; 22(12):1239-43. PubMed ID: 9877261
[TBL] [Abstract][Full Text] [Related]
24. Moderate-intensity regular exercise decreases serum tumor necrosis factor-alpha and HbA1c levels in healthy women.
Tsukui S; Kanda T; Nara M; Nishino M; Kondo T; Kobayashi I
Int J Obes Relat Metab Disord; 2000 Sep; 24(9):1207-11. PubMed ID: 11033992
[TBL] [Abstract][Full Text] [Related]
25. Novel interactions of adiponectin with the endocrine system and inflammatory parameters.
Fernández-Real JM; López-Bermejo A; Casamitjana R; Ricart W
J Clin Endocrinol Metab; 2003 Jun; 88(6):2714-8. PubMed ID: 12788878
[TBL] [Abstract][Full Text] [Related]
26. Plasma soluble tumour necrosis factor-alpha receptor 2 is elevated in obesity: specific contribution of visceral adiposity.
Cartier A; Côté M; Bergeron J; Alméras N; Tremblay A; Lemieux I; Després JP
Clin Endocrinol (Oxf); 2010 Mar; 72(3):349-57. PubMed ID: 19650780
[TBL] [Abstract][Full Text] [Related]
27. Lowered tumor necrosis factor receptors, but not increased insulin sensitivity, with infliximab.
Di Rocco P; Manco M; Rosa G; Greco AV; Mingrone G
Obes Res; 2004 Apr; 12(4):734-9. PubMed ID: 15090644
[TBL] [Abstract][Full Text] [Related]
28. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.
Yu JG; Javorschi S; Hevener AL; Kruszynska YT; Norman RA; Sinha M; Olefsky JM
Diabetes; 2002 Oct; 51(10):2968-74. PubMed ID: 12351435
[TBL] [Abstract][Full Text] [Related]
29. Plasma soluble tumor necrosis factor-alpha receptors circulate in proportion to leptin levels during the menstrual cycle in lean but not in obese women.
Fernández-Real JM; Gutierrez C; Vendrell J; Casamitjana R; Ricart W
Eur J Endocrinol; 2000 Aug; 143(2):235-41. PubMed ID: 10913943
[TBL] [Abstract][Full Text] [Related]
30. Associations between insulin resistance and TNF-alpha in plasma, skeletal muscle and adipose tissue in humans with and without type 2 diabetes.
Plomgaard P; Nielsen AR; Fischer CP; Mortensen OH; Broholm C; Penkowa M; Krogh-Madsen R; Erikstrup C; Lindegaard B; Petersen AM; Taudorf S; Pedersen BK
Diabetologia; 2007 Dec; 50(12):2562-71. PubMed ID: 17928988
[TBL] [Abstract][Full Text] [Related]
31. Body fat changes and activity of tumor necrosis factor α system--a 5-year follow-up study.
Olszanecka-Glinianowicz M; Chudek J; Kocełak P; Szromek A; Zahorska-Markiewicz B
Metabolism; 2011 Apr; 60(4):531-6. PubMed ID: 20580040
[TBL] [Abstract][Full Text] [Related]
32. Circulating tumor necrosis factor alpha is higher in non-obese, non-diabetic Mexican Americans compared to non-Hispanic white adults.
Ho RC; Davy KP; Hickey MS; Melby CL
Cytokine; 2005 Apr; 30(1):14-21. PubMed ID: 15784408
[TBL] [Abstract][Full Text] [Related]
33. Relationships between serum adiponectin and soluble TNF-α receptors and glucose and lipid oxidation in lean and obese subjects.
Adamska A; Nikołajuk A; Karczewska-Kupczewska M; Kowalska I; Otziomek E; Górska M; Strączkowski M
Acta Diabetol; 2012 Feb; 49(1):17-24. PubMed ID: 21234613
[TBL] [Abstract][Full Text] [Related]
34. Subcutaneous adipose tissue expression of tumour necrosis factor-alpha is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects.
Koistinen HA; Bastard JP; Dusserre E; Ebeling P; Zegari N; Andreelli F; Jardel C; Donner M; Meyer L; Moulin P; Hainque B; Riou JP; Laville M; Koivisto VA; Vidal H
Eur J Clin Invest; 2000 Apr; 30(4):302-10. PubMed ID: 10759878
[TBL] [Abstract][Full Text] [Related]
35. Obesity, and not insulin resistance, is the major determinant of serum inflammatory cardiovascular risk markers in pre-menopausal women.
Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Sancho J; San Millán JL
Diabetologia; 2003 May; 46(5):625-33. PubMed ID: 12739017
[TBL] [Abstract][Full Text] [Related]
36. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression.
Bulló M; García-Lorda P; Megias I; Salas-Salvadó J
Obes Res; 2003 Apr; 11(4):525-31. PubMed ID: 12690081
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance.
Hotamisligil GS; Arner P; Atkinson RL; Spiegelman BM
Diabetes; 1997 Mar; 46(3):451-5. PubMed ID: 9032102
[TBL] [Abstract][Full Text] [Related]
38. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.
Kern PA; Di Gregorio GB; Lu T; Rassouli N; Ranganathan G
Diabetes; 2003 Jul; 52(7):1779-85. PubMed ID: 12829646
[TBL] [Abstract][Full Text] [Related]
39. Circulating TNF-alpha and leptin levels in offspring of NIDDM patients do not correlate to individual insulin sensitivity.
Kellerer M; Rett K; Renn W; Groop L; Häring HU
Horm Metab Res; 1996 Dec; 28(12):737-43. PubMed ID: 9013754
[TBL] [Abstract][Full Text] [Related]
40. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
